XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Nonvested Restricted Shares
A summary of changes in the Company’s nonvested restricted shares for the nine months ended September 30, 2021 follows:
SharesWeighted-Average
Grant-Date
Fair Value, per share
Nonvested at January 1, 2021
4,130 $14.63 
Granted
4,008 13.33 
Vested
(5,655)13.61 
Forfeited
— — 
Nonvested at September 30, 2021
2,483 $14.86 
Summary of Fair Value of Options Granted Using Weighted Average Assumptions
The fair value of options granted during the nine months ended September 30, 2021 were determined using the following weighted average assumptions as of grant date:
September 30, 2021
Risk-free interest rate (%)
0.82 
Expected term (years)
7.50
Expected stock price volatility (%)
29.57 
Dividend yield (%)
1.82 
Summary of Activity in the Equity Plan
A summary of the activity in the Equity Plan for the nine months ended September 30, 2021 follows:
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (in years)
Aggregate
Intrinsic
Value
Outstanding at January 1, 2021
332,708 $16.01 
Granted
127,275 14.67 
Exercised
— — 
Forfeited
(540)15.11 
Expired
(4,665)16.52 
Outstanding at September 30, 2021
454,778 $15.63 7.96$2,436 
Vested and exercisable at September 30, 2021
180,318 $16.52 7.16$842